Literature DB >> 9530419

Financial impact of the 1995 outbreak of vesicular stomatitis on 16 beef ranches in Colorado.

A M Hayek1, B J McCluskey, G T Chavez, M D Salman.   

Abstract

OBJECTIVE: To determine financial impact of an outbreak of vesicular stomatitis in the San Luis Valley of southern Colorado.
DESIGN: Survey and financial analysis. SAMPLE POPULATION: 16 ranchers whose beef herds were affected by the 1995 outbreak. PROCEDURE: Information concerning financial effects during the outbreak year was collected by personal interview of each rancher and examination of financial records.
RESULTS: Affected herds ranged from 79 to 956 cows (mean, 345). Cow case-fatality rates ranged from 0 to 80%, with calf case-fatality rates ranging from 0 to 28% and overall case-fatality rates of 0 to 15%. Median financial loss was $7,818/ranch and mean financial loss was $15,565/ranch, excluding total financial losses associated with sale of calves. Primary financial losses for these beef herds were attributed to increased culling rates, death of pregnant cows, loss of income from calves, and costs for additional labor during the outbreak. Some costs were attributable to a decrease in market price for beef and a drought during the year after the outbreak. CLINICAL IMPLICATIONS: Financial losses for an outbreak of vesicular stomatitis can be attributed to effects of the disease and costs associated with imposed quarantines.

Entities:  

Mesh:

Year:  1998        PMID: 9530419

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  2 in total

1.  Moving the glycoprotein gene of vesicular stomatitis virus to promoter-proximal positions accelerates and enhances the protective immune response.

Authors:  E B Flanagan; L A Ball; G W Wertz
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

Review 2.  Immunovirotherapy Based on Recombinant Vesicular Stomatitis Virus: Where Are We?

Authors:  Yuguo Zhang; Bolni Marius Nagalo
Journal:  Front Immunol       Date:  2022-06-28       Impact factor: 8.786

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.